Canada | NATO DIANA Energy & Power 2026
On-edge, multi-diagnostic AI for real-time detection of traumatic torso injuries with ultrasound
NATO DIANA 2026 Cohort
Deep Breathe Inc. specializes in AI-powered portable lung imaging, combining lung ultrasound with advanced artificial intelligence techniques. Their core offering is an autonomous diagnostic solution for various respiratory diseases and potentially traumatic torso injuries. This technology aims to make accurate lung assessments universally accessible.
Deep Breathe differentiates itself through its unique blend of portable lung ultrasound with advanced, autonomous AI interpretation, making diagnostics radiation-free and universally accessible. The technology is designed to be vendor-agnostic, allowing for broader integration and flexibility. Their diverse team of software developers, engineers, clinicians, and ultrasound experts also provides a unique interdisciplinary advantage.
Defense analysts should care about Deep Breathe's potential to revolutionize real-time diagnostics for traumatic torso injuries and various lung conditions in austere environments. Its portable, AI-driven approach offers critical advantages for military operations, where rapid and accurate assessments can significantly impact combat casualty care and survivability. The ability to perform radiation-free diagnostics anywhere aligns perfectly with forward operating base requirements.
The return on investment for defense would be realized through improved diagnostic speed and accuracy, leading to better patient outcomes and reduced mortality rates in combat or disaster zones. It minimizes the need for costly and logistically challenging evacuations for basic diagnostics, saving resources and personnel. The radiation-free aspect also reduces long-term health risks for personnel.
Currently in the Incubator/Accelerator - III stage, Deep Breathe's technology is demonstrating early-stage viability and is actively developing its core AI and ultrasound integration. This indicates a technology readiness level where proof-of-concept is established and development is ongoing towards a deployable product. They have announced FDA clearance, suggesting progress towards market readiness.
Deep Breathe Inc. develops AI-powered portable lung ultrasound for real-time, accurate, and radiation-free diagnostics of respiratory diseases and traumatic torso injuries. Their technology empowers both healthcare providers and laypersons to perform critical lung assessments anywhere, including military operations, aerospace missions, and emergency response. It offers a significant leap in accessible, autonomous medical imaging.